Xie, Y.; Shi, Z.; Qian, Y.; Jiang, C.; Liu, W.; Liu, B.; Jiang, B.
HDAC2- and EZH2-Mediated Histone Modifications Induce PDK1 Expression through miR-148a Downregulation in Breast Cancer Progression and Adriamycin Resistance. Cancers 2022, 14, 3600.
https://doi.org/10.3390/cancers14153600
AMA Style
Xie Y, Shi Z, Qian Y, Jiang C, Liu W, Liu B, Jiang B.
HDAC2- and EZH2-Mediated Histone Modifications Induce PDK1 Expression through miR-148a Downregulation in Breast Cancer Progression and Adriamycin Resistance. Cancers. 2022; 14(15):3600.
https://doi.org/10.3390/cancers14153600
Chicago/Turabian Style
Xie, Yunxia, Zhumei Shi, Yingchen Qian, Chengfei Jiang, Wenjing Liu, Bingjie Liu, and Binghua Jiang.
2022. "HDAC2- and EZH2-Mediated Histone Modifications Induce PDK1 Expression through miR-148a Downregulation in Breast Cancer Progression and Adriamycin Resistance" Cancers 14, no. 15: 3600.
https://doi.org/10.3390/cancers14153600
APA Style
Xie, Y., Shi, Z., Qian, Y., Jiang, C., Liu, W., Liu, B., & Jiang, B.
(2022). HDAC2- and EZH2-Mediated Histone Modifications Induce PDK1 Expression through miR-148a Downregulation in Breast Cancer Progression and Adriamycin Resistance. Cancers, 14(15), 3600.
https://doi.org/10.3390/cancers14153600